FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: The Feasibility and Benefits of Applying PERCIST

Background: We aimed to examine the feasibility and potential benefit of applying PET Response Criteria in Solid Tumors (PERCIST) for response monitoring in metastatic breast cancer (MBC). Further, we introduced the nadir scan as a reference. Methods: Response monitoring FDG-PET/CT scans in 37 women...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogsen, Marianne, Bülow, Jakob Lykke, Ljungstrøm, Lasse, Oltmann, Hjalte Rasmus, Alamdari, Tural Asgharzadeh, Naghavi-Behzad, Mohammad, Braad, Poul-Erik, Gerke, Oke, Hildebrandt, Malene Grubbe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073831/
https://www.ncbi.nlm.nih.gov/pubmed/33921580
http://dx.doi.org/10.3390/diagnostics11040723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073831/
https://www.ncbi.nlm.nih.gov/pubmed/33921580
http://dx.doi.org/10.3390/diagnostics11040723

Ejemplares similares